SHERRY ANDERSON: Open Payments
NPI 1386772622 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,781 in 86 payments from 20 companies in 2025. Trend: 2023 $1,484 · 2024 $2,433 · 2025 $1,781
Food & beverage: $1,673Education: $109
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 15 | $445 |
| ABBVIE INC. | 18 | $242 |
| Novartis Pharmaceuticals Corporation | 14 | $207 |
| Galderma Laboratories, L.P. | 13 | $172 |
| Janssen Biotech, Inc. | 2 | $124 |
| Lilly USA, LLC | 1 | $87 |
| PFIZER INC. | 4 | $81 |
| GENZYME CORPORATION | 3 | $62 |
| UCB, Inc. | 2 | $57 |
| Incyte Corporation | 2 | $49 |
Products named: DUPIXENT, NEMLUVIO, SKYRIZI, COSENTYX, TREMFYA, RINVOQ, EBGLYSS, CIBINQO.
Industry payments across GA — which companies pay providers there.
